Questions about this study?
The HopeStage team will email you.
Get research updatesListed age limits: 18 years to 60 years.
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
HDAC Inhibitor Augmentation to Clozapine
The HopeStage team will email you.
Locations not listed
The study sponsor is Virginia Commonwealth University, a university.
Yes. The study involves medication, including Vorinostat Oral Capsule Group 1 and Vorinostat Oral Capsule Group 2.
Listed age limits: 18 years to 60 years.
The registry lists this study as withdrawn.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me